Nebulized Hypertonic Saline for Bronchiolitis

• Status: Completed
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to examine the effect of nebulized 3% hypertonic saline in the treatment of viral bronchiolitis. The investigators hypothesize that nebulized 3% saline will decrease rate of hospital admission, decrease clinical severity scores, and decrease length of stay.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Children's Hospital Los Angeles
• Collaborators: Children's Hospital & Research Center Oakland; Thrasher Research Fund; UCSF Benioff Children's Hospital Oakland

Criteria

Inclusion Criteria:

• clinical diagnosis of viral bronchiolitis

• between November and April

Exclusion Criteria:

• prematurity < 34 weeks

• chronic lung disease

• congenital heart disease

• history of wheezing, asthma or albuterol use

• tracheostomy status

• need for intensive care of assisted ventilation